Search

Certain chemotherapies are associated with an increased long-term risk of subsequent tumors in survivors of childhood cancer, according to a study led by researchers at UT Southwestern Medical Center.

Like falling dominoes, a sequence of activity in an area of the zebra finch brain plays to completion once initiated, allowing these birds to produce their full courtship song, a study led by UT Southwestern Medical Center researchers shows.

UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness.

UT Southwestern Medical Center has been selected to operate the new Texas Behavioral Health Center – the first state acute care behavioral health hospital in the Dallas-Fort Worth area – announcing plans to care for its first patients this summer.

UT Southwestern Medical Center is one of the 10 best large employers in the United States and among the top 5 health care employers, according to the America’s Best Employers 2022 list compiled by Forbes and Statista.

UT Southwestern Medical Center has completed a five-year, $1 billion campaign to fuel its commitment to advance brain research and clinical care at its Peter O’Donnell Jr. Brain Institute, making it one of the largest brain-focused investments at a U.S. academic medical center.

A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, featured in npj Digital Medicine, could

A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical Center researchers suggests.

Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT Southwestern Medical Center, a new study shows. The findings, published in Cancer Discovery by a team at

A program that asks patients to mail in stool samples to screen for colon cancer is an effective way to expand screenings to underserved and underinsured communities and offers an alternative to in-person testing during the pandemic, according to a study conducted by UT Southwestern.